| 英文别名 |
9DD4NXS7RD;Osimertinib metabolite M1;BDBM50260359;J3.657.495J;2-Propenamide, N-(2-((2-(dimethyloxidoamino)ethyl)methylamino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl)amino)phenyl)-;N,N-Dimethyl-2-[[2-(acryloylamino)-5-methoxy-4-[[4-(1-methyl-1H-indole-3-yl)-2-pyrimidinyl]amino]phenyl](methyl)amino]ethanamineoxide;N-(2-((2-(Dimethyloxidoamino)ethyl)methylamino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl)amino)phenyl)-2-propenami;Unii-9DD4nxs7RD;AZD9291 Osimertinib Impurity 2;2-((2-Acrylamido-5-methoxy-4-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)(methyl)amino)-N,N-dimethylethan-1-amine oxide;2-((2-Acrylamido-5-methoxy-4-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)(methyl)amino)-N,N-dimethylethan-1-amine oxide;UNII-9DD4NXS7RD;UNII-9DD4NXS7RD;Osimertinib N'-Oxide;Osimertinib N'-Oxide;Osimertinib Impurity M;Osimertinib Impurity M;CHEMBL4079658;CHEMBL4079658;N-(2-((2-(Dimethyloxidoamino)ethyl)methylamino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl)amino)phenyl)-2-propenamide;N-(2-((2-(Dimethyloxidoamino)ethyl)methylamino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl)amino)phenyl)-2-propenamide;1975982-94-5;1975982-94-5;OsimertinibN'-Oxide;OsimertinibN'-Oxide;2-[5-methoxy-N-methyl-4-[[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino]-2-(prop-2-enoylamino)anilino]-N,N-dimethylethanamine oxide;2-[5-methoxy-N-methyl-4-[[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino]-2-(prop-2-enoylamino)anilino]-N,N-dimethylethanamine oxide |
